Muscle Pharm Corporation (MSLPQ)

[TheExpertHimself]

There have been 3 board members resigning at the same time....some very bullish sales projections have been delivered by management and multiple marketing contracts have been signed while the company's liquidity is limited.

Furthermore, Ceo's stocks he pledged to secure some loan, which we have no disclosures about, had a margin call/defaulted last month.

On the same day we were made aware of this margin call, the company changed it's company bylaws....and a few days later during conference call, we were told that the company had no problem fixing it's loan issues by Estalella....but we have never told what happened to the waiver for credit line that expired May 31.


When shareholders aren't given any information about such material things, they might tend to start speculating what exactly it was that fixed it's credit problems? and what that made 3 board members resign at the same time?

Whether it's worthy to support Wynnefield Capital's initiative is a personal choice, in America, any shareholder should however be allowed to raise whatever questions he deems necessary...if there is something that appears to be important, that hasn't been disclosed.

Change of shares outstanding and many other issues of interest to shareholders are normally disclosed at earnings and conference calls. However, when it is in the shareholders' interests to disclose something that is truly material information at time of event, I would assume it would be in the interests of a shareholder friendly company to do so.